文献速递血栓与止血造血干细胞移植与细胞治疗

Serglycin控制巨核细胞对血小板因子4的保留并影响骨髓中巨核细胞的命运

Serglycin controls megakaryocyte retention of platelet factor 4 and influences megakaryocyte fate in bone marrow.
PubMed 文献 · Blood Adv · 2025-01-01

本研究发现,α颗粒内蛋白聚糖serglycin(SRGN)通过保留血小板因子4(PF4)等因子,在巨核细胞(MK)成熟过程中发挥关键作用;SRGN-/-未成熟MK释放约80%的PF4,其条件培养基在体外负向影响野生型MK分化,SRGN-/-小鼠骨髓中PF4、TGF-β1、IL-1β和TNF-α间质积聚,未成熟MK增多,并伴有轻度血小板减少、造血干细胞和多能祖细胞减少、层粘连蛋白减少及I型胶原沉积增加。

要点

  • SRGN-/-未成熟MK释放约80%的PF4,其条件培养基负向影响野生型MK分化。
  • SRGN-/-小鼠骨髓间质积聚PF4、TGF-β1、IL-1β和TNF-α,未成熟MK增多,与轻度血小板减少一致。
  • SRGN-/-小鼠造血干细胞和多能祖细胞减少,层粘连蛋白减少,I型胶原沉积增加。

核心结论

  • 巨核细胞依赖SRGN及其带电荷的糖胺聚糖(GAG)来平衡PF4及其他因子在α颗粒与邻近细胞外间隙之间的分布,破坏此平衡会负向影响MK发育和骨髓微环境稳态。

研究设计与样本

  • 研究使用SRGN-/-小鼠与野生型MK进行体外和体内实验,观察MK成熟过程中PF4释放、条件培养基对野生型MK分化的影响,以及SRGN-/-小鼠骨髓因子积聚、MK数量、造血干细胞和多能祖细胞数量及细胞外基质成分的变化。

主要发现

  • 未成熟SRGN-/- MK释放约80%的PF4,其条件培养基在体外负向影响野生型MK分化。
  • 用多阳离子surfen(已知的糖胺聚糖/蛋白相互作用抑制剂)处理野生型MK可重现上述效应。
  • SRGN-/-小鼠骨髓间质积聚PF4、转化生长因子β1、白细胞介素1β和肿瘤坏死因子α,未成熟MK数量增多,与轻度血小板减少一致。
  • SRGN-/-小鼠造血干细胞和多能祖细胞数量减少,层粘连蛋白减少,I型胶原沉积增加。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Megakaryocytes (MKs) produce platelets, and similar to other hematopoietic progenitors, they are involved in homeostatic aspects of their bone marrow niche. MKs release and endocytose various factors, such as platelet factor 4 (PF4)/CXCL4. Here, we show that the intra-α-granular proteoglycan, serglycin (SRGN), plays a key role in this process by retaining PF4, and perhaps other factors, during MK maturation. Immature, SRGN-/- MKs released ∼80% of their PF4, and conditioned media from these cells negatively affected wild-type MK differentiation in vitro. This was replicated in wild-type MKs by treatment with the polycation surfen, a known inhibitor of glycosaminoglycan (GAG)/protein interactions. In vivo, SRGN-/- mice had an interstitial accumulation of PF4, transforming growth factor β1, interleukin-1β, and tumor necrosis factor α in their bone marrow and increased numbers of immature MKs, consistent with their mild thrombocytopenia. SRGN-/- mice also had reduced numbers of hematopoietic stem cells and multipotent progenitors, reduced laminin, and increased collagen I deposition. These findings demonstrate that MKs depend on SRGN and its charged GAGs to balance the distribution of PF4 and perhaps other factors between their α-granules and their adjacent extracellular spaces. Disrupting this balance negatively affects MK development and bone marrow microenvironment homeostasis.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Lykins J, Becker IC, Camacho V, et al. Serglycin controls megakaryocyte retention of platelet factor 4 and influences megakaryocyte fate in bone marrow. Blood Adv. 2025. PMID: 38941534. doi:10.1182/bloodadvances.2024012995

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。